ACTH(22-39)
CPFX4158
immunoglobulin light chain variable region fragment [Homo sapiens]
Mutated EGFR-IN-1
Naquotinib
Icotinib
RA371
Fmoc-Val-Cit-PAB
Ald-Ph-NHS ester
PPD 10558
LSP-249
Glycohyodeoxycholic Acid
SLF-amido-C2-COOH
(S,R,S)-AHPC-C5-COOH
Azido-PEG1-CH2CO2H
Propargyl-PEG2-Tos
FR054
Simurosertib
GSK319347A
Scutebata G
Tetrahydro tanshinone I
3-Oxosapriparaquinone
alpha-Epoxydihydroartemisinic acid
(±)-α-Bisabolol
Antitumor agent-56
Anamorelin Fumarate
2-Deoxy-2-sulfoamino-D-glucose sodium
Indomethacin heptyl ester
Guanidinosuccinic acid
Indirubin-3'-monoxime-5-sulphonic acid
PIH
Acetyl-L-lysine
BCMA72-80 acetate(2293841-58-2 free base)
cis-9,10-Epoxystearic acid
Theogallin
Cas9-IN-3
P7C3
Caerulein,desulfated
MBM-17S
Obafluorin
Amosulalol,(+)-
Amosulalol HCl
DBIBB
5-HT6/5-HT2A receptor ligand-1
Viloxazine
AMG-548 dihydrochloride
LSN3106729 hydrochloride
Bensulfuron-methyl
Symplostatin 1
SEP-363856
Cetyldimethylethylammonium Bromide
(R)-Oxybutynin
Nitroxoline
Gatifloxacin mesylate
Ro 24-6392
Isobutyl-deoxynyboquinone
P7C3-OMe
Fmoc-Val-Cit-PAB-Duocarmycin TM
Ftase inhibitor III
CID 5951923
